Catalyst Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Catalyst Pharmaceuticals, Inc.

Aug-25	Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals CPRX GlobeNewswire
Aug-06	Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update CPRX GlobeNewswire
Aug-06	Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC) CPRX GlobeNewswire
Aug-04	Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors CPRX GlobeNewswire
Jul-22	Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 CPRX GlobeNewswire
Jun-02	Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer CPRX GlobeNewswire
May-07	Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update CPRX GlobeNewswire